Anthony O'Brien Biography and Net Worth

Director of Evofem Biosciences


Mr. O'Brien has served as a member of the Evofem Biosciences board of directors since January 2018. He served as the Director General of Ireland's Health Service Executive, or HSE. an organization responsible for the provision of health and personal social services for the residents of Ireland from July 2012 to May 2018. Prior to his role as Director General, Mr. O'Brien was the Chief Operating Officer of the Department of Health's Special Delivery Unit and a member of the Department's Management Board. Mr. O’Brien previously served as Director of Clinical Strategy and Programs in the HSE and Chief Executive Officer of the National Treatment Purchase Fund.

Mr. O'Brien served as Chief Advisor to the HSE on the implementation of the National Cancer Control Strategy, Project Director for the National Plan for Radiation Oncology and is a former Chairman of the National Cancer Registry Board. Mr. O'Brien was the founding Chief Executive Officer of the National Cancer Screening Service from 2007 to May 2011, Director of BreastCheck, CervicalCheck and an Associate and Interim Director of the National Cancer Control Programme. Prior to joining the HSE, Mr. O'Brien served as Chief Executive of the Irish Family Planning Association and as the Chief Executive of the UK Family Planning Association.

Mr. O'Brien is a Council Member and Associate Faculty Member of the Irish Management Institute, a former Member of the Healthy Ireland Council and a Chartered Director of the Institute of Directors in Ireland. Mr. O’Brien also currently serves as a director and owner of Global Leadership And Governance Solutions Limited, a private limited company organized in the Republic of Ireland.  Mr. O'Brien also holds a Master of Sciences in Management Practice from Trinity College, University of Dublin. Mr. O'Brien is Adjunct Assistant Professor in Health Strategy and Management at Trinity College Dublin.

How do I contact Anthony Stephen O'Brien?

The corporate mailing address for Mr. O'Brien and other Evofem Biosciences executives is 12400 HIGH BLUFF DRIVE SUITE 600, SAN DIEGO CA, 92130. Evofem Biosciences can also be reached via phone at (858) 550-1900 and via email at [email protected]. Learn More on Anthony Stephen O'Brien's contact information.

Has Anthony Stephen O'Brien been buying or selling shares of Evofem Biosciences?

Anthony Stephen O'Brien has not been actively trading shares of Evofem Biosciences within the last three months. Learn More on Anthony Stephen O'Brien's trading history.

Who are Evofem Biosciences' active insiders?

Evofem Biosciences' insider roster includes Russell Barrans (Insider), Justin File (CFO), Alexander Fitzpatrick (General Counsel), Kim Kamdar (Director), Anthony O'Brien (Director), Saundra Pelletier (CEO), and Lisa Rarick (Director). Learn More on Evofem Biosciences' active insiders.

Anthony Stephen O'Brien Insider Trading History at Evofem Biosciences

See Full Table

Anthony Stephen O'Brien Buying and Selling Activity at Evofem Biosciences

This chart shows Anthony Stephen O'brien's buying and selling at Evofem Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evofem Biosciences Company Overview

Evofem Biosciences logo
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.03
Low: $0.02
High: $0.03

50 Day Range

MA: $0.03
Low: $0.02
High: $0.04

2 Week Range

Now: $0.03
Low: $0.01
High: $4.38

Volume

2,047,930 shs

Average Volume

820,510 shs

Market Capitalization

$1.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A